← FDA Drug Approvals (Drugs@FDA)

BUMETANIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2018-04-30

Drug application

FDA Application #

ANDA202900

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUMETANIDE

Generic name

BUMETANIDE

Active ingredients

BUMETANIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Pharmaceuticals (USA) Inc.

First approval

2018-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown